• Mental Health Innovation at large substances - Cares Act. Telehealth and controlled substance prescribing habits for serious mental illness. Extension of Public Health Emergency Act for telehealth. Senate drug pricing reforms under Medicare Part D. TRIPS Waiver. Fixes to the Inflation Reduction Act of 2022 (P.L.117-169). Mental Health Care - PPD screening guidelines in Momnibus bills (H.R.3305/S.1606).
• Telehealth Medicare physician reimbursement. P.L.117-169 - Inflation Reduction Act of 2022 and potential fixes to the IRA. Maternal mental health legislation, like Momnibus (H.R.3305/S.1606).

Duration: May 23, 2019 to present

General Issues: Health Issues, Medicare/Medicaid, Medical/Disease Research/Clinical Labs, Trade (Domestic & Foreign), Copyright/Patent/Trademark, Budget/Appropriations, Pharmacy

Spending: about $3,880,277 (But it's complicated. Here's why.)

It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.

Agencies lobbied since 2019: House of Representatives, U.S. Senate, Centers For Medicare and Medicaid Services (CMS), Substance Abuse & Mental Health Services Administration (SAMHSA), Office of the Vice President of the United States, Health & Human Services - Dept of (HHS)